Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Long Beach, California 90806


Purpose:

The purpose of this study is to evaluate the safety and tolerability of combined ciclesonide nasal spray administered along with a fixed combination of inhaled fluticasone dipropionate/salmeterol.


Criteria:

Main Inclusion Criteria: - General good health, other than perennial allergic rhinitis - History and diagnosis of perennial allergic rhinitis by skin prick - Normal body weight as defined by the study protocol Main Exclusion Criteria: - Pregnancy, nursing, or plans to become pregnant or donate gametes (ova or sperm) for in vitro fertilization during the study period or for 30 days following the study period - Participation in any investigational drug trial within the 30 days preceding the Screening Visit - A known hypersensitivity to any corticosteroid or any of the excipients in the formulations - Use of any prohibited concomitant medications as defined by the study protocol - Previous participation in an intranasal ciclesonide study - Non-vaccinated exposure to or active infection with, chickenpox or measles within the 21 days preceding the Screening Visit


NCT ID:

NCT00163488


Primary Contact:

Study Director
AstraZeneca AstraZeneca
AstraZeneca


Backup Contact:

N/A


Location Contact:

Long Beach, California 90806
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.